Publication | Closed Access

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults

VaccinationLyophilized FormulationsPhase I/iia SafetyMalariaImmunologyVaccine TestingMalaria-naïve AdultsMedicine